To explore the predictive value of radiomics models based on endorectal ultrasound (ERUS) images for KRAS gene mutations in rectal cancer patients.
Methods:
A total of 225 patients with rectal cancer admitted to Fujian Medical University Union Ho
spital were included in this study. Those patients were randomly separated into training cohort (191 cases) and testing cohort (34 cases) according to the ratio of 17∶3. The ERUS images of each patient’s clearest and deepest tumor infiltration section were selected for manual segmentation and feature extraction. After dimensionality reduction and selection
three classification algorithms
logistic regression (LR)
support vector machine (SVM) and random forest (RF) were used to construct models to predict the
KRAS
gene status of rectal cancer. Receiver operating characteristic (ROC) curve
calibration curve and decision curve analysis (DCA) were drawn to evaluated the predictive performance
goodness of fit and clinical value of the models
respectively. DeLong test was used to compare the efficiency differences of the three models.
Results:
After features selection
the best 8 features were used to construct models for predicting
KRAS
gene mutations in rectal cancer patients. The area under the curve (AUC) of SVM
LR and RF models were 0.94
0.93
0.91 and 0.82
0.88
0.85 in the training cohort and testing cohort
respectively. There was no significant difference in the AUC of the three models ( all
P
>0.05 ) by DeLong test. The DCA showed that all three models had certain clinical benefits
and the LR model had the highest clinical benefit in the testing cohort. The calibration curve showed that the three models fitted well.
Conclusion:
The radiomics models of ERUS images have great predictive value for
KRAS
gene mutations in rectal cancer. It can be used as a supplementary method for non-invasive evaluation of
KRAS
gene mutations in rectal cancer patients and has great guiding significance for clinical selection of targeted therapy.